购物车
- 全部删除
- 您的购物车当前为空
Pivagabine (CXB-722) 是疏水性 4-氨基丁酸的衍生物,具有神经调节活性。它可穿透大鼠的血脑屏障,拮抗足部休克对大鼠脑中 GABAA 受体功能和促肾上腺皮质激素释放因子 (CRF) 浓度的影响。
为众多的药物研发团队赋能,
让新药发现更简单!
Pivagabine (CXB-722) 是疏水性 4-氨基丁酸的衍生物,具有神经调节活性。它可穿透大鼠的血脑屏障,拮抗足部休克对大鼠脑中 GABAA 受体功能和促肾上腺皮质激素释放因子 (CRF) 浓度的影响。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 283 | 现货 | |
2 mg | ¥ 395 | 现货 | |
5 mg | ¥ 662 | 现货 | |
10 mg | ¥ 1,070 | 现货 | |
25 mg | ¥ 1,790 | 现货 | |
50 mg | ¥ 2,680 | 现货 | |
100 mg | ¥ 3,930 | 现货 | |
500 mg | ¥ 8,390 | 现货 |
产品描述 | Pivagabine (CXB-722), a hydrophobic 4-aminobutyric acid derivative, exhibits neuromodulatory activity and successfully penetrates the blood-brain barrier in rats. It counteracts the impact of foot shock on GABAA receptor function and corticotropin-releasing factor (CRF) levels in the rat brain. |
体内活性 | Pivagabine(CXB 722)(200 mg/kg;腹腔注射;每天两次,连续四天,并在第五天处死前1小时)可阻止足底电击应激对两个脑区CRF浓度的影响[2]。 |
动物实验 | Pivagabine (CXB 722) (200 mg/kg; i.p.; twice a day for 4 days and 1 hour before killing on the 5th day) prevents the effects of foot-shock stress on CRF concentration in both brain regions, reduced by 52% the CRF concentration in the hypothalamus but had no effect on that in the cerebral cortex[2]. |
别名 | 匹伐加宾, CXB-722 |
分子量 | 187.24 |
分子式 | C9H17NO3 |
CAS No. | 69542-93-4 |
Smiles | CC(C)(C)C(=O)NCCCC(O)=O |
密度 | 1.053 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 45 mg/mL (240.33 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容